Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
Go back to Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio| CHIMERIX (NASDAQ: CMRX) | Delayed: 8.54 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.54 | 52 Week High | $42.24 | |||
| Open | $8.54 | 52 Week Low | $3.50 | |||
| Day High | $8.54 | P/E | N/A | |||
| Day Low | $8.54 | EPS | $-0.47 | |||
| Volume | 100 | |||||
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 246.98 +2.02 (0.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $244.96 | 52 Week High | $160.00 | |||
| Open | $244.00 | 52 Week Low | $95.80 | |||
| Day High | $248.19 | P/E | 45.91 | |||
| Day Low | $243.16 | EPS | $5.38 | |||
| Volume | 142,589 | |||||
